0001846639-23-000005.txt : 20230726
0001846639-23-000005.hdr.sgml : 20230726
20230725215244
ACCESSION NUMBER: 0001846639-23-000005
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230726
DATE AS OF CHANGE: 20230725
EFFECTIVENESS DATE: 20230726
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valliance Asset Management Ltd
CENTRAL INDEX KEY: 0001846639
IRS NUMBER: 000000000
STATE OF INCORPORATION: K3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-21042
FILM NUMBER: 231109923
BUSINESS ADDRESS:
STREET 1: 16/F, 8 QUEEN'S ROAD
CITY: CENTRAL
STATE: K3
ZIP: 000000
BUSINESS PHONE: 852 35657001
MAIL ADDRESS:
STREET 1: 16/F, 8 QUEEN'S ROAD
CITY: CENTRAL
STATE: K3
ZIP: 000000
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001846639
XXXXXXXX
06-30-2023
06-30-2023
Valliance Asset Management Ltd
16/F, 8 QUEEN'S ROAD
CENTRAL
K3
000000
13F HOLDINGS REPORT
028-21042
000310059
802-119486
N
Larri Harold BALLIN
Chief Compliance Officer
(852) 35657005
Larri Harold BALLIN
Hong Kong
K3
07-24-2023
0
4
6261116
false
INFORMATION TABLE
2
Valliance_13F_06302023.xml
HH&L ACQUISITION CO*W EXP 02/04/202G397141298000400000SHSOLE40000000TAIWAN SEMICONDUCTOR MFG LTDSPONSORED ADS874039100399996439635SHSOLE3963500YS BIOPHARMA CO LTD*W EXP 03/15/202G9845F11735250750000SHSOLE75000000YS BIOPHARMA CO LTDORDINARY SHARESG9845F10922179021607175SHSOLE160717500